Trial site
Instytut MSF Sp. z o.o.
- 22running trials
- 12closed trials
The trials here
What the 34 trials at this site are about, from their registry records.
- Conditions
- Lung cancer20 trials
- Metastatic breast cancer10 trials
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Pancreatic cancer2 trials
- Cervical cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- and 1 more
- Phase
- Phase 327 trials
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed12 trials
- Recruiting12 trials
- Active, not recruiting9 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca5 trials
- Pfizer4 trials
- AstraZeneca AB2 trials
- BioNTech SE2 trials
- Regeneron Pharmaceuticals2 trials
- and 18 more
Running trials
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
Active, not recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Active, not recruiting
Recruiting
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer8 recruiting
- Metastatic breast cancer3 recruiting
- Bladder cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026